Study Evaluating Inotuzumab Ozogamicin (CMC-544) Plus Rituximab In Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Public ClinicalTrials.gov record NCT00867087. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-label, Single-arm, Phase 2 Study Of Inotuzumab Ozogamicin Plus Rituximab In Subjects With Relapsed/Refractory Cd22-positive Diffuse Large B-cell Lymphoma, Eligible For Autologous Stem Cell Transplantation
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate inotuzumab ozogamicin in combination with rituximab prior to an autologous stem cell transplant (aSCT) in patients with relapsed/refractory diffuse large B-cell Non-Hodgkin's lymphoma.
Study identification
- NCT ID
- NCT00867087
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 64 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 8, 2009 (Actual)
- Primary completion
- Oct 31, 2012 (Actual)
- Completion
- Oct 31, 2012 (Actual)
- Last update posted
- Dec 5, 2017
2009 – 2012
United States locations
- U.S. sites
- 21
- U.S. states
- 9
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Loyola University Medical Center, Foster G. McGraw Hospital and Satellites | Maywood | Illinois | 60153 | — |
| Tufts Medical Center | Boston | Massachusetts | 02111 | — |
| University of Michigan Comprehensive Cancer Center | Ann Arbor | Michigan | 48109 | — |
| Siteman Cancer Center | City of Saint Peters | Missouri | 63376 | — |
| Barnes-Jewish Hospital | St Louis | Missouri | 63110-1094 | — |
| Washington University School of Medicine | St Louis | Missouri | 63110 | — |
| John Theurer Cancer Center (JTCC) at Hackensack University Medical Center (HUMC) | Hackensack | New Jersey | 07601-1941 | — |
| John Theurer Cancer Center (JTCC) at Hackensack University Medical Center (HUMC) | Hackensack | New Jersey | 07601-2105 | — |
| Hackensack University Medical CenteR | Hackensack | New Jersey | 07601 | — |
| John Theurer Cancer Center (JTCC) at Hackensack University Medical Center (HUMC) | Hackensack | New Jersey | 07601 | — |
| John Theurer Cancer Center, Hackensack University Medical Center | Hackensack | New Jersey | 07601 | — |
| Memorial Sloan - Kettering Cancer Center | New York | New York | 10065 | — |
| Penn State Milton S Hershey Medical Center | Hershey | Pennsylvania | 17033-0850 | — |
| UT Southwestern University Hospital - St. Paul | Dallas | Texas | 75235 | — |
| Zale Lipshy University Hospital | Dallas | Texas | 75235 | — |
| UT Southwestern Medical Center | Dallas | Texas | 75390 | — |
| The University of Texas, M. D. Anderson Cancer Center | Houston | Texas | 77030-4009 | — |
| University of Texas, MD Anderson Cancer Center | Houston | Texas | 77030 | — |
| Methodist Healthcare System of | San Antonio | Texas | 78229 | — |
| University of Wisconsin Hospital and Clinics | Madison | Wisconsin | 53792-0001 | — |
| Pharmaceutical Research Center | Madison | Wisconsin | 53792 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 14 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00867087, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 5, 2017 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00867087 live on ClinicalTrials.gov.